| Multiple Myeloma |
1 |
1 |
| Stem Cell Research and Therapy |
0 |
0.99 |
| Transplantation |
0 |
0.98 |
| Cell Transplantation |
0 |
0.97 |
| Transplant Center |
0 |
0.45 |
| Cancer |
0 |
0.21 |
| Chemotherapy |
0 |
0.21 |
| Insurance |
0 |
0.21 |
| Acute Myeloblastic Leukemia |
0 |
0.15 |
| Toxicology |
0 |
0.12 |
| Revenue and Practice Management |
0 |
0.11 |
| Social Determinants of Health |
0 |
0.11 |
| Clinical Guidelines |
0 |
0.1 |
| Health Care Economics |
0 |
0.1 |
| Hematologic Malignancies |
0 |
0.1 |
| Leukemia |
0 |
0.1 |
| Match |
0 |
0.1 |
| New York |
0 |
0.1 |
| Primary Care |
0 |
0.1 |
| Psychosocial |
0 |
0.1 |
| Refractory |
0 |
0.1 |
| Remission |
0 |
0.1 |
| Socioeconomics |
0 |
0.1 |
| Myelodysplastic Syndrome |
0 |
0.09 |
| Acute Leukemia |
0 |
0.08 |